Jagsonpal Pharmaceuticals Q4 FY26 Earnings Conference Call

Jagsonpal Pharmaceuticals Ltd scheduled a conference call for April 28, 2026, to discuss its Q4 FY26 financial results.
The event is part of the company's investor engagement activities and will feature MD Manish Gupta and CFO Nirav Vora.
Dial-in details and a registration link were provided, with the company stating the call is in compliance with SEBI LODR Regulation 30.
No unpublished price sensitive information (UPSI) is expected to be shared during the call as per the standard disclosure.